Zebrafish as a genetic model in pre-clinical drug testing and screening

Area of Science:

• Pharmacology
• Toxicology
• Developmental Biology

Background:

• Traditional drug discovery is complex and costly.
• Zebrafish present a viable alternative model organism for drug development.
• Their biological characteristics are suitable for screening, gene discovery, and toxicity testing.

Purpose of the Study:

• To review the application of zebrafish in preclinical drug development.
• To highlight advances in zebrafish-based drug screening and toxicology.
• To underscore the value of zebrafish as a model organism in drug discovery.

Main Methods:

• High-throughput small molecule screening using zebrafish embryos.
• Forward and reverse genetics for gene discovery and functional studies.
• Zebrafish disease modeling for mechanism of action and in vivo validation.
• Toxicity and ecotoxicology testing in zebrafish.

Main Results:

• Zebrafish facilitate cost-effective, high-throughput screening.
• Genetic manipulation enables detailed gene and functional studies.
• Zebrafish models accurately represent human diseases for validation.
• The organism is well-suited for comprehensive toxicity assessments.

Conclusions:

• Zebrafish are a versatile model organism for preclinical drug development.
• Recent advances significantly enhance zebrafish capabilities in drug discovery and toxicology.
• The use of zebrafish streamlines multiple stages of the drug discovery pipeline.